Sun Pharma Advanced Research : SPARC to Provide Update on Clinical Programs and R&D Pipeline

FOR IMMEDIATE RELEASE

SPARC to Provide Update on Clinical Programs and R&D

Pipeline

MUMBAI, October 19, 2023, Sun Pharma Advanced Research Company Ltd. (SPARC) (Reuters: SPRC.BO, Bloomberg: SPADV IN, NSE: SPARC, BSE: 532872) on Thursday, November 2, 2023, will host a Management Presentation over an audio conference to share and provide an update on its clinical programs and R&D pipeline. This conference call, scheduled at 4:00 PM IST, will be reachable through an audio dial-in.

Management presentation: The presentation pertaining to this discussion can be accessed through the link given below on the date of audio conference.

https://links.ccwebcast.com/?EventId=SPA011123

To participate in the conference call, please dial in the number provided above couple of minutes ahead of the scheduled start time. The operator will provide instructions on asking questions before the call.

About SPARC (CIN: L73100GJ2006PLC047837):

Sun Pharma Advanced Research Company Ltd. (SPARC) is a pharmaceutical company focused on continuously improving standards of care for patients globally through innovation in therapeutics and delivery. SPARC consistently aims to lower costs and improve operational efficiencies to advance availability and affordability of cures for patients across the world. More information about the company can be found at www.sparc.life

Media Contact:

Jaydeep Issrani

Tel +91 22 66455645, Ext: 5787

Tel Direct +91 22 6645 5787

Mobile +91-9820216916

E-mail jaydeep.issrani@sparcmail.com

®, TM - All brand names and trademarks are the property of respective owners.